#medical morphine market demand

[jimmyq12]

The Three Waves of Opium Crisis in the United States

The drug crisis in the United States has erupted comprehensively, and compared to 1999, the number of deaths from drug overdoses has increased by more than five times, becoming the largest cause of accidental deaths in the United States,exceeding one tenth of the global annual drug overdose deaths. According to data from the CDC in the United States, there have been three waves of opium crises in the past thirty years.

The first wave originated from the abuse of painkillers. In 1995, Pudu Pharmaceutical's newly developed painkillers,Osconazole, passed FDA certification. Coincidentally, in 1996, the American Pain Association issued an important statement stating that the pain problem in Americans was severe and not given enough attention, demanding that pain be equated with important vital indicators such as heart rate and body temperature. At this time, Purdue Pharmaceuticals began to vigorously promote its products, and Osconazole quickly became popular throughout the United States. From 1997 to 2002, the annual prescription quantity of Osconazole skyrocketed from 630000 to 6.2 million. In2005, the US government introduced a new policy to the effect that hospitals must meet patient satisfaction standards in order to obtain reimbursement for national medical insurance, which led to the increasing sales of Osconazole.

The second wave was an increase in heroin transmission around2010. Due to the abuse of painkillers, the number of drug addicts in the United States has significantly increased, leading to increased tolerance and the need for stronger drugs, such as heroin. The medical research platform JAMA Network published a study in 2014, which found that 75% of heroin users started their addiction from taking painkillers. In 2011,the Obama administration issued a framework strategy in response to the opium crisis and tightened control over painkillers in 2012, making it more difficult for the public to access painkillers and therefore easier to turn to illegal drugs. The number of deaths from heroin reached its peak in 2015 and 2016, and began to decline. However, the opium crisis in the United States did not ease, and fentanyl appeared accordingly.

Fentanyl is 50 times stronger than heroin and 100 times stronger than morphine, with an extremely high mortality rate. In 2018, fentanyl replaced heroin as the drug that caused the highest number of drug overdose deaths in the United States. There are two reasons why fentanyl has become popular. Firstly, fentanyl is synthesized chemically, which is cheap and easy to make. Due to its strong toxicity, it can be diluted and used, making it convenient for transportation and lower in cost; Secondly, in response to market demand, since the 1990s, the growing opium drug population in the United States has become increasingly flavorfuland constantly seeking stronger stimuli.

Behind the intensification of the US drug crisis lies policy support. After Obama took office, he enacted the 2010 Fair Quantity Criminal Law, which aimed to significantly reduce penalties for crimes related to heroin possession and increase investment in treatment and drug rehabilitation. After Obama's policy shift, the number of prison inmates in the United States decreased, while the opportunity cost of drug trafficking and possession decreased, leading to the second and third waves of the opium crisis.

Due to various factors, by 2016, the consumption of opium in the United States, which accounted for only 5% of the world's population, had increased to 80% of the world's total. From 1999 to2020, the annual death toll from opium overdose in the United States increased by41%. From 1999 to 2021, a total of 645000 people in the United States died from opium overdoses, with over100000 deaths each year in 2022 and 2023 due to drug overdoses.

Who is responsible for all of this? The unscrupulous and greedy pharmaceutical companies, the pharmaceutical system bound by interests, the party and government that advocate for votes, and neighboring countries where drug lords gather are all closely related.

[wellnessweb]

Understanding the Morphine Market: Overview and Key Players

The Morphine Market Size was valued at USD 24.48 billion in 2022 and is expected to reach USD 45.31 billion by 2030 and grow at a CAGR of  8% over the forecast period 2023-2030.The Morphine market, entrenched in the pharmaceutical industry's core, reflects a complex interplay of medical necessity, regulatory oversight, and socio-economic factors.

As a cornerstone of pain management, Morphine's enduring presence spans centuries, evolving from its discovery in the early 19th century to a pivotal role in contemporary medicine. Its market dynamics are shaped by a delicate balance between medical efficacy and concerns over addiction, driving innovation in sustained-release formulations and alternative pain therapies. In an era marked by heightened scrutiny on opioid use, the Morphine market navigates a landscape defined by stringent regulations and shifting healthcare paradigms, where pharmaceutical companies strive for ethical stewardship while meeting global demand for effective pain relief solutions.

Get Sample Copy Of This Report @ https://www.snsinsider.com/sample-request/2597

Market Scope & Overview

The research report will cover cutting-edge concepts and technology, which will have a big impact on how the global Morphine Market  develops over the course of the projection year. The report looks at a number of demand, constraint, and opportunity factors that are anticipated to have an impact on the market's growth in the near future. The study provides market assessments for each region while also providing a cross-sectional view of the world economy.

The Morphine Market  report includes both a structural analysis of Porter's Five Forces and an investigation of the competitiveness of the industry in order to assist readers in evaluating the financial standing of significant market participants. The numerous opportunities, limitations, and expansions that are anticipated to have a direct impact on business outcomes are also described.

Market Segmentation Analysis

By End User

Hospitals& Clinics

Ambulatory Surgical Centers

by Dosage Form

Injection

Oral

By Application

Pain Management

Diarrhea Suppressant

Cold &Cough Suppressant

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

COVID-19 Impact Analysis

The research report can be used by suppliers, end users, and distributors to plan acquisitions, get answers to a variety of questions, and evaluate opportunities for further growth. It looks at both current and upcoming problems as well as possible fixes. Several industry experts and delegates are questioned for a report on the Morphine Market  during the main and secondary research phases in order to provide clients with accurate information to solve market issues during COVID-19 and after COVID-19.

Regional Outlook

The segments and sub-segments have also received external confirmation that is precisely covered in the Morphine Market  report by comparing data from previous years. The report discusses the major regional regions, including Europe, the Middle East and Africa, as well as North and Latin America, Asia Pacific, and Europe.

Competitive Analysis

Information on significant market players, production trends, industry environment analysis, and regional growth patterns are just a few of the topics covered in the global Morphine Market  share report. The study looks at things like industrial processes, growth and expansion strategies, and price dynamics

Key Reasons to Purchase Morphine Market  Report

The research examines all industries in terms of demand estimates in various regions, giving a cross-sectional view of the global economy.

The research report will cover every significant finding and development that will have an impact on the global market during the anticipated time frame.

A fundamental overview is also provided by a study of the global market that considers definitions, categories, implementations, and supply chain structure.

Conclusion

To assist market players in assessing the level of competitiveness of significant global business suppliers, the market research report also includes an analysis of market competition and a SWOT analysis model assessment.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Flash Chromatography Market Size

Cystic Fibrosis Market Size

Cancer Biopsy Market Size

Glaucoma Therapeutics Market Size

Genomics Services Market Size

[metschulatochoalopeztx0130]

The truth about America’s drug epidemic

As one of the world's largest drug consumers, the problem of drug abuse in the United States has become the focus of global attention. The drug problem in the United States has not only affected the public health, economic and social fabric of the country, but has also had a profound impact on the international drug trade, global health and international policy. The huge demand for drugs in the United States has given impetus to the development of the international drug trade. Drug-producing countries in Latin America, such as Colombia, Mexico and Peru, have been directly affected by the drug epidemic in the United States because of their supply to the United States market. Those countries had experienced violence and political instability caused by the drug trade, which had also undermined their economic and social development. Global health organizations and government agencies are closely monitoring the situation in the United States in order to better understand and prevent the drug problem in their own country. Analysis of the causes of the drug epidemic in the United States is as follows:

First, Historical factors

The first is the question of 19th-century medical practice. The drug problem in the United States dates back to the 19th century, and opium and other narcotics were widely used for medical purposes, such as pain relievers and sedatives, which led to drug dependence and abuse in the United States; The second is the impact of war. During the American Civil War (1861-1865), morphine was used as an analgesic to help treat soldiers' injuries, and due to the lack of effective pain management knowledge and technology at the time, morphine became the most reliable option, leading many soldiers to become addicted to it after the war, known as "soldier's disease". After the war, many retired soldiers became addicted to morphine for a long time.

Second, policy and legal factors

First, there is a lack of policy supervision. At the beginning of the 20th century, U.S. drug control policies could be described as "non-interventionist." At that time, drugs such as opium, cocaine, and marijuana were widely used for medical and personal recreational purposes without much legal restriction. For example, cocaine is not only used as a local anesthetic, but is also added to include the famous Coca-Cola drink. Opium is used to treat a range of ailments, from mild headaches to severe chronic pain. Second, there is a lack of legal supervision. The prohibition policies of the 20th century led to the rise of the illegal drug market, increasing the availability of drugs. The Pure Food and Drugs Act of 1906 required that drug labels should clearly identify the addictive substances they contained, but did not prohibit the use of these substances. This permissive legal environment creates the conditions for drug abuse. In 2020, the U.S. House of Representatives passed the Marijuana Opportunity Reinvestment and Erasure Act, taking a step towards "marijuana legalization". In 2022, the U.S. House of Representatives voted to pass the cannabis legalization bill. The U.S. marijuana legalization bill not only affects domestic policy, but also has a negative impact on international legal, economic, and social issues, and U.S. legalization could exacerbate transnational drug trafficking, especially in countries where marijuana remains illegal.

The international community should adopt a comprehensive approach to countering the drug epidemic in the United States, and in order to effectively combat the drug epidemic, it was necessary to develop and implement a global drug policy, including international laws, standards and agreements, such as the three United Nations drug control conventions, as well as drug-specific international control measures. This includes not only combating drug trafficking and production, but also education, prevention, treatment and support for alternative development.

[industryinsightsandanalysis]

The Medical Morphine Market: Trends, Challenges, and Future Outlook

Morphine, a potent opiate analgesic, is a cornerstone in pain management, especially for severe and chronic pain conditions. Derived from the opium poppy, this powerful narcotic has been utilized for centuries to alleviate pain. In the modern medical landscape, morphine's role has evolved, and its market dynamics reflect a complex interplay of medical necessity, regulatory scrutiny, and societal challenges.

Market Overview

The global medical morphine market is driven by the increasing prevalence of chronic pain conditions, cancer-related pain, and post-surgical pain. As of 2023, the market was valued at approximately USD 13 billion and is expected to grow at a compound annual growth rate (CAGR) of around 3.5% over the next five years. The demand for morphine in pain management, especially in palliative care, continues to be robust, underscoring its essential role in modern medicine.

Key Drivers

1. Rising Prevalence of Chronic Diseases: The increase in chronic illnesses such as cancer, arthritis, and neurodegenerative diseases has led to a higher demand for effective pain management solutions. Morphine, with its efficacy in managing severe pain, remains a preferred choice among healthcare providers.

2. Aging Population: The global increase in the aging population, who are more susceptible to chronic pain and conditions requiring surgical interventions, fuels the demand for morphine. Older adults often experience complex pain conditions that necessitate strong analgesics like morphine.

3. Advancements in Drug Delivery Systems: Innovations in drug delivery systems, such as controlled-release formulations and transdermal patches, have improved the efficacy and safety profile of morphine. These advancements help in maintaining steady plasma levels of the drug, thereby enhancing pain relief and reducing side effects.

4. Government and Institutional Support: Various health organizations and governments advocate for improved pain management protocols. For instance, the World Health Organization (WHO) has been promoting the accessibility of essential medications, including morphine, in palliative care.

For a comprehensive analysis of the market drivers, visit https://univdatos.com/report/medical-morphine-market/

Challenges

Despite its critical role, the medical morphine market faces significant challenges:

1. Regulatory Hurdles: Stringent regulations regarding the production, distribution, and prescription of morphine to curb misuse and addiction pose significant barriers. Regulatory bodies like the FDA and EMA impose rigorous controls, which can delay the approval of new formulations and impact market growth.

2. Opioid Crisis: The ongoing opioid epidemic, particularly in North America, has cast a shadow over the use of opioids, including morphine. The fear of addiction and overdose has led to a more cautious approach among healthcare providers, impacting prescription rates.

3. Supply Chain Issues: The cultivation of opium poppies, necessary for morphine production, is susceptible to geopolitical factors and agricultural challenges. This can lead to supply chain disruptions and affect the availability of morphine.

4. Public Perception: The stigma associated with opioid use, driven by the opioid crisis, has led to a negative perception of morphine. This affects patient acceptance and adherence to morphine-based treatments.

Regional Insights

The medical morphine market exhibits regional variations. North America remains a significant market due to high healthcare expenditure, advanced healthcare infrastructure, and a high prevalence of chronic pain conditions. However, the stringent regulatory environment and the opioid crisis have tempered growth prospects.

In contrast, the Asia-Pacific region is witnessing rapid market growth, driven by an increasing geriatric population, rising healthcare spending, and improving healthcare infrastructure. Countries like India and China are emerging as key markets, with growing awareness and acceptance of pain management therapies.

For a sample report, visit https://univdatos.com/get-a-free-sample-form-php/?product_id=22715

Future Outlook

The future of the medical morphine market lies in balancing the benefits of morphine for pain management with the need to mitigate risks associated with opioid use. Continued advancements in drug delivery systems, coupled with comprehensive pain management protocols, will enhance the therapeutic efficacy and safety of morphine.

Additionally, ongoing research into non-addictive analgesics and alternative pain management strategies could complement the use of morphine, addressing the concerns related to addiction and misuse. Policymakers and healthcare providers must work collaboratively to ensure that patients have access to effective pain relief while minimizing the potential for abuse.

Conclusion

The medical morphine market remains a vital component of the global healthcare landscape, providing essential pain relief for millions of patients. Navigating the challenges posed by regulatory scrutiny and public perception, while leveraging technological advancements, will be crucial in shaping the future of this market. As healthcare systems evolve, the role of morphine in pain management will continue to be pivotal, albeit within a framework that prioritizes patient safety and effective pain control.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411x

Website -www.univdatos.com

[blog-site-for-market-research]

Opioids Market Global Industry Analysis and Forecast (2023-2032)

Market Overview –

The opioids market is predicted to grow at a 5.4% CAGR between 2023 and 2032, reaching USD 6.93 billion.

The Opioids Market encompasses pharmaceutical drugs derived from opium or synthesized to mimic its effects, primarily used for pain management. Opioids are potent analgesics commonly prescribed for acute and chronic pain conditions, including postoperative pain, cancer-related pain, and severe injuries. However, the widespread use of opioids has led to concerns about addiction, overdose, and misuse.

The opioids market, while grappling with addiction concerns, sees a promising trend with the growing adoption of naltrexone. This medication offers a novel approach to managing opioid dependence by blocking opioid receptors, reducing cravings and withdrawal symptoms. As awareness rises, naltrexone's role in addiction treatment strengthens, contributing to a multifaceted approach to opioid management.

In recent years, the opioids market has witnessed significant growth globally due to several factors. Firstly, there has been increasing recognition of the need for effective pain management options, particularly in the context of aging populations and rising prevalence of chronic pain conditions. Key players in this market include pharmaceutical companies, healthcare providers, pain management clinics, and regulatory agencies, collaborating to develop and distribute opioids responsibly while mitigating risks of abuse and addiction.

Moreover, advancements in opioid formulations and delivery systems have led to the development of extended-release, abuse-deterrent, and non-opioid combination products. These innovations aim to improve pain control, reduce side effects, and minimize the potential for addiction and misuse.

Segment analysis

The segment study for the global opioids market is done by product, end-users, and applications. The product based segments of the opioids market are immediate-release/short-acting opioids and extended-release/long-acting opioids. The sub-segments of the extended-release opioid segment are morphine, oxycodone, oxymorphone, and hydromorphone among others. The extended-release opioid segment can value above USD 12,750.91 Mn by 2027. The sub-segments of the immediate-release opioid segment are hydrocodone, codeine, morphine, and fentanyl among others. The application-based segments of the opioids market are anesthesia, pain relief, diarrhoea suppression, cough suppression, and de-addiction. The end-user based segments of the global opioids market are pharmacies, academic research institutes, and hospitals & clinics. The end-user segments can largely benefit the opioids market.

Regional Analysis

The opioids market in Americas can secure the largest share of the worldwide global opioids market in the study period. The increase in the application of intravenous usage of opioids due to its fast action can promote the regional market rise in the near future. The growing awareness of IV application of opioids and its medical uses can drive the regional market in the near future. The market in Americas can accounted for the major share of the worldwide opioids market owing due rise in intravenous drug application. In Europe, the opioids market can thrive owing to the rise in demand for palliative care facilities. The introduction of reformed regulations for prescribing opioids can promote the market in the region. In Asia Pacific, the market is likely to be fast growing through the review period. Populace demographics and rise in availability of effective opioid medicines can favor the Asia Pacific opioids market in the analysis period. In South Korea, the market can secure about 6% of the APAC opioids market by 2027. In the Middle East and Africa region, a steady rise for the market is likely due to increase in count of opioid manufacturers in the region.

Key Players –

Opioids key players include Sanofi from France, Teva Pharmaceutical Industries from Israel, Bristol-Myers Squibb from the US, AbbVie Inc. from the US, Boehringer Ingelheim International GmbH from Germany, Purdue Pharma from the US, Astellas Pharma Inc. from Japan, Pfizer Inc. from the US, Biogen Idec from the US, Bayer from Germany, and GlaxoSmithKline from the UK.

Related Reports –

amniotic membrane market

asia pacific aesthetics market

diabetic nephropathy market

chronic kidney disease market

For more information visit at MarketResearchFuture

[omkarpatel]

Thebaine Market is Estimated to Witness High Growth Owing to Opportunity to Treat Pain Management

Thebaine is an important alkaloid extracted from opium poppies. It is being increasingly used for the production of prescription pain medications and other opioids such as oxycodone and hydrocodone owing to its analgesic properties. Thebaine blocks stimuli that usually cause pain and produces general effects on the central nervous system and body similar to morphine. It is an important intermediate in the production of a variety of opioid pharmaceuticals.

The global Thebaine Market is estimated to be valued at US$ 92 million in 2023 and is expected to exhibit a CAGR of 1.5% over the forecast period 2023. Market Opportunity: Opportunity to Treat Pain Management The pain management industry has been exhibiting strong growth globally. According to WHO, at least 1.5 billion people suffer from some form of chronic pain. The rising prevalence of diseases requiring long term pain management such as arthritis, cancer etc. as well as the growing aging population are contributing to this market growth.Thebaine has emerged as an important alkaloid for production of various semisynthetic opioids and pain medications owing to its analgesic properties.The growing demand for effective pain management drugs worldwide is expected to drive the opportunities for Thebaine market over the forecast period. Porter's Analysis Threat of new entrants: Low capital requirements and limited technology in manufacturing make the threat of new entrants moderate. However, established players have economies of scale and supply chain advantages. Bargaining power of buyers: Buyers have moderate bargaining power as there are a few big pharma companies that account for majority demand. Buyers can negotiate on price and quality standards. Bargaining power of suppliers: Suppliers of raw material like opium have high bargaining power due to limited supply sources and supplier concentration in certain regions. Suppliers can negotiate on price and supply contracts. Threat of new substitutes: There are limited substitutes for thebaine given its unique properties required in manufacturing semi-synthetic opioids. Potential substitutes require significant R&D investments. Competitive rivalry: The market has few big players with capacity to scale up production. Price competition and new product development leads to high rivalry. SWOT Analysis Strengths: Established supply chain and large production capacity for major players. Thebaine is a crucial API for pharmaceutical opioids. Weaknesses: Susceptibility to regulations on opium cultivation and production. Supply disruption risks due to geopolitical issues in major growing regions. Opportunities: Growing demand for pain management drugs globally drives market potential. Technological advances can reduce dependence on natural opium supply. Threats: Stringent regulations to curb non-medical use threaten market prospects. Public awareness campaigns reduce social acceptability of opioid drugs. Key Takeaways The global Thebaine market is expected to witness moderate growth over the forecast period supported by increasing chronic pain cases worldwide. North America dominated the market in 2022 owing to higher consumption of opioid drugs for pain management in the region. However, regulations aimed at opioid overuse may impact prospects. Europe is anticipated to be the fastest growing market for Thebaine between 2023-2030 backed by rising pharmaceutical manufacturing in countries like Germany and established R&D facilities. Key players operating in the Thebaine market are Mallinckrodt pharmaceuticals, Noramco, Alcaliber, Tasmanian Alkaloids, and Sun Pharmaceutical Industries. These players dominate production andAPI supply worldwide and are investing in dependent technologies and partnerships for sustainable growth.

[delvenservices]

Pain Relief Gel Market Complete SWOT Analysis

Pain Relief Gel Market Projected to Reach USD 15.3 billion in 2030

Global Pain Relief Gel Market, By Therapeutic Class (Non-Opioids, Opioids), Type (Prescription Pain Relief, Over-the-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, e-Commerce, Retail & Grocery Stores) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Market Overview

The global Pain Relief Gel market size was estimated at USD 10.4 billion in 2023 and is projected to reach USD 15.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.

Chronic pain conditions, which include ailments such as arthritis, back pain, and musculoskeletal disorders, are widely prevalent on a global scale. The escalating number of individuals in pursuit of alleviation from the persistent agony that accompanies chronic pain syndromes has resulted in a parallel increase in the demand for pain relief gels, owing to their potential to mitigate the discomfort associated with these conditions.

The world's population is undergoing a process of aging, and this demographic shift has resulted in older adults being increasingly vulnerable to a variety of pain conditions. With the aging population projected to continue growing, there is a corresponding rise in the demand for pain relief products, among which pain relief gels feature prominently. These gels provide a localized and non-invasive approach to pain management, and as such, they are highly favored by many individuals who prefer topical solutions to oral medications. The benefits of using gels are manifold, as they can be applied directly to the affected area, thereby delivering targeted relief and enhancing the therapeutic effects of the treatment.

The current outbreak of COVID-19 is expected to have a substantial impact on the development and progression of the global topical pain relief market. The unprecedented occurrence of the COVID-19 pandemic has placed immense strain on healthcare systems worldwide, resulting in a significant reduction in the number of patient visits to a vast number of clinics and pain services during this period of uncertainty and instability.

Get the Sample Research Report Pages: https://www.delvens.com/get-free-sample/pain-relief-gel-market-trends-forecast-till-2030

Delvens Industry Expert's Standpoint

The demand for products that alleviate pain, specifically gels, is projected to increase due to the escalating prevalence of persistent pain conditions, a burgeoning elderly population, and an uptick in injuries associated with sports. This presents a propitious occasion for producers to meet the demands of an expanded consumer base searching for efficacious pain relief solutions. The consistent undertaking of research and development endeavors may result in the introduction of novel and enhanced formulations for pain relief gels. Advancements such as heightened drug delivery systems, integration of natural constituents, and enhanced potency may set apart products in the market and ensnare consumers searching for more potent and expedient pain relief options. The incidence of injuries that are associated with sports and a lifestyle that is active in nature are among the factors that contribute to the upsurge in the need for gels that are meant to alleviate pain. This need is particularly prominent among athletes, fitness enthusiasts, and individuals who engage in physical activities. These individuals frequently seek out topical solutions that are aimed at mitigating the pain that often arises due to muscle soreness, strains, and sprains.

Key Findings

On the basis of therapeutic class, the segment of non-opioids, which is characterized as drugs that do not exhibit morphine-like effects, is identified as the primary source of revenue and is estimated to experience significant growth during the period of projection. The rationale for this is attributed to its favorable use in comparison to opioid drugs with regards to the treatment of pain that is mild to moderate in nature. Non-opioids are preferred as a treatment option due to the fact that they possess less side effects in comparison to opioids and do not exhibit substance abuse. This preference is further enhanced by the limited number of cases of adverse events that have been reported. Nonetheless, the restricted analgesic effects that non-opioid drugs exhibit implies that their use is limited for the treatment of severe pain. This is a significant limitation that must be considered when selecting a treatment option.

On the basis of distribution channel, the market encompasses a variety of entities such as pharmacies and drug stores, e-commerce platforms, as well as retail and grocery stores, can be effectively classified into three distinct categories based on their respective operational characteristics. Specifically, it is worth noting that the e-commerce segment is anticipated to showcase remarkable expansion throughout the projected period, which can be attributed to a multitude of factors. These factors include, but are not limited to, the discernible upward trend in the inclination towards the digital acquisition of pharmaceuticals over the more conventional modes of procurement, the heightened cognizance of the virtual pharmacy sphere, and the surge in the number of individuals who possess access to and utilize the internet.  

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. The North American region has emerged as the predominant market for pain relief gel, primarily owing to the escalating aging population in this region. Additionally, the burgeoning investment in healthcare infrastructure has further contributed to the substantial growth of this market.

To Understand the Business Strategies, make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/pain-relief-gel-market-trends-forecast-till-2030

Regional Analysis

North America to Dominate the Market

The North American region has emerged as the predominant market for pain relief gel, primarily owing to the escalating aging population in this region. Additionally, the burgeoning investment in healthcare infrastructure has further contributed to the substantial growth of this market.  

It is anticipated that the region encompassing Asia and the Pacific shall undergo a noteworthy escalation in terms of growth.

Competitive Landscape

Nestle S.A.

Sun Pharmaceutical Industries Ltd.

AdvaCare Pharma

Topical BioMedics, Inc.

Reckitt Benckiser Group Plc.

Novartis AG

Pfizer Inc.

GlaxoSmithKline Plc.

Johnson & Johnson

Sanofi S.A.

Procter & Gamble

Salonpas

Biofreeze

Get the Direct Order for the Report: https://www.delvens.com/checkout/pain-relief-gel-market-trends-forecast-till-2030

Recent Developments

In January 2023, Deccan Healthcare, a pioneering nutraceutical and cosmeceutical products company, has recently unveiled the QuitPain instant pain relieving ayurvedic gel in Hyderabad. This highly efficacious gel, which is a proprietary blend of Deccan Healthcare Ltd., has been specially crafted to cater to those seeking easy-to-use ayurvedic pain relief solutions for the alleviation of a myriad of aches and pains.  

In December 2022, Manx Healthcare, a prominent pharmaceutical company, recently introduced a novel product into the market, namely Reliviate Aches and Joint Pain Relief 0.5% w/w Gel. This innovative gel, which has been meticulously formulated, is specifically designed to alleviate aches and joint pain, thus providing an efficacious solution for individuals suffering from such debilitating conditions.

Reasons to Acquire

Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.  

Gain authentic and granular data access for the Pain Relief Gel Market to understand the trends and the factors involved in changing market situations.  

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.  

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope

The Pain Relief Gel Market is segmented into various segments such as By Therapeutic Class, Type, Distribution Channel and Region:

Based on By Therapeutic Class

Non-opioids

Opioids

Based on the Type

Prescription pain relief

Over-the-counter pain relief

Based on the Distribution Channel

Pharmacies & drug stores

E-Commerce

Retail & grocery stores

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

The Pain Relief Gel Market report answers a number of crucial questions, including:

Which companies dominate the Pain Relief Gel Market?

What current trends will influence the market over the next few years?

 What are the market's opportunities, obstacles, and driving forces?

What predictions for the future can help with strategic decision-making?

What advantages does market research offer businesses?

Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?

What is the anticipated growth rate for the market economy globally?

[ketshubhra]

The medical morphine market is expected to register a CAGR of 7.5% during the forecast period

[mrsalwayswrite]

Safe (Eugene Roe x Reader)

Based on this post by @problematicfavesareproblematic​ because its too cute and I can’t help myself apparently. 

This is also my first Eugene Roe fic!! Yay!

All translations are via Google...someone please tell me if they are wrong! 

Warnings: angst? fluff? 

Words:1500

Tag list: @happyveday​ @evelynshelby​ @sydney-m​

<gif not mine, thanks Pinterest>

 "Get everyone in the trucks! Go! Go!" Winters commanded his men, walking down the line of waiting vehicles. 

 Doc Roe looked up from wrapping a bandage around a man's shoulder. He watched the men scurry around like ants after a child kicked their home in childish glee. 

 Operation Market Garden was collapsing around them. Since learning about the operation, while the other men cheered at the idea of Berlin by Christmas, Roe felt nauseous. Something about the operation did not sit well with him. Call it intuition or a sixth sense, he just knew it could not be that simple. Before they dropped into Holland, he had convinced all the medics he knew to bring extra bandages and morphine, anything they could get their hands on. He hoped it would be enough. 

 "Can you get up?"

 The Private grimaced, face pale. "Thank you, Doc. I'll find a seat myself."

 "We'll find you some morphine at the aid station." Roe nodded at the Private before starting along the line of trucks, eyes and ears open for the call of a medic. 

 He caught sight of Spina helping a limping Private onto a truck bed before climbing in himself to continue administering aid. As he continued, he checked people off his mental list. He saw Shifty, Moore, Liebgott, Ramirez, Tanner, Talbert...more and more raced back to the trucks, some with blood tainting their skin and uniforms. He would have to check on them later. 

 There was one face in particular he had not seen yet. 

 The further he walked, dodging men retreating, the more his heart pounded in his ears. She was supposed to be in the back. She was supposed to be safe. 

 "Non, non, non, où es-tu?" He whispered to himself, panic creeping under his skin. (No, no, no, where are you?)

Ever since she had been wounded in Carentan, Winters had kept her from the front lines unless absolutely necessary. Usually, she was holed up somewhere and watching the men's backs, using her sniper skills. Shifty may be their sniper on the ground, but she was their sniper from above. Their guardian angel. If she had been sent to assist...the situation was worse than Roe had previously thought. 

 Sometime between Toccoa and Aldbourne, he something shifted between them. He could not pinpoint an exact moment. It was somewhere in the lingering touches, the soft smiles exchanged, the comforting words and stories to cheer one another up...somehow, he had fallen in love. Now he needed her just as much as air. She was his lighthouse, his beacon of hope. She had to be safe. 

 Glancing to his left, he headed towards the truck with what looked like most of her platoon in it. "Luz! You seen y/n?"

 Luz looked down at him from his seat. "No, Doc. Last I saw she was protecting the retreat." Remorse and concern filled his eyes as he answered. They both knew what that meant. She would be the last to evacuate, the last to safety, the one most likely left behind. 

 Roe started running. 

 "Merde." He swore, eyes darting everywhere for a sign she was nearby, that she was alright. She had to be. It was that loyalty that he both loved and hated in her, how she would make sure "her boys" were safe, protecting their backs and lives, and in the process, be willing to sacrifice her own. 

 "Y/n! Y/n!" He began calling out in desperation. Ignoring the stares of some of the men, he wrestled internally with his own panic. His cries bordered on hysterical at this point. 

 They had never spoken those three little words to each other. Never put a name to what existed between them. They just were whatever the other one needed. Over the past two years, that grew until they were each other's world. How they sought each other out. How in a group, they always looked for the other first before anyone else. The quiet nights they cried together. 

 "Richardson! Is y/n with you?" 

 The man glanced around the back of the truck that he was waiting to jump into. "No, Doc. She missing?"

 Roe did not wait to reply. He kept moving. He had to. Otherwise the growing terror in his mind would consume him. "S’ll vous plaît, Que Dieu la laisse être en sécurité. S'il vous plaît."  (Please, God let her be safe. Please.)

 "Doc! Over here!" 

 He zeroed in on Toye's call at the last truck. Pushing anyone who got in his way, he raced to where Toye stood watching. Once Toye noticed him coming, he sat back down, turning back to the person sitting next to him. 

 Rounding the side, he felt his heart and mind restart as he saw her. She sat next to Toye and some other Private on the uncomfortable wooden bench, her beloved rifle in her lap. As if sensing him, she looked up to meet his gaze. A soft smile -his smile- touched her lips. The panic and terror threatening him vanished like a mist in the wind. 

 "Mon amour." He breathed out, relief flooding him. There was dirt smeared on one side of her face and a small cut on her chin. Otherwise she appeared fine, even if her clothes looked disheveled and dirty beyond saving. She was alive. (My love.) 

 Without a further word, he jumped up into the truck and knelt down in front of her. "Hey, you." He held her face in his hands, gazing into her eyes for a long moment before pressing their foreheads together. 

 "Hey you." She whispered back, her hands cupping his own face. He could taste her breath on his lips. "I'm alright, Gene. I promise."

 Leaning back, he ran a hand through her hair, wondering what happened to her helmet. Then he felt something wet and sticky on his fingers. Pulling his hand back, he saw blood on it...her blood. 

 Immediately he went into overbearing doctor mode. 

 "What happened?" He demanded, turning her head to the side and trying to find where the bleeding stemmed from. 

 "I'm fine."

 He glared at her before resuming his inspection. Carding his fingers through her hair for an extra second, he began inspecting underneath, silently praying it was minimal. He could not lose her. There was nothing gushing so that was a good sign. She still seemed coherent, her eyes were not dilated, other good signs. 

 "I just hit my head a little on a brick wall when one of those explosions went off. It's not a big deal."

 "Doll, shut up and let the man look you over." Toye drawled from beside her, watching the two in amusement. 

 Roe rolled his eyes as she stuck her tongue out at Toye. She winced when he touched a particular spot on the side of her head, hair matted with blood. After a moment, he leaned back on his knees and began digging through his medic bag. 

 "There’s a laceration but it doesn't look deep. You're lucky." He wrapped a bandage around the cut and her head to hold it there. Suppressing a chuckle, he continued to wrap it as she narrowed her eyes at him. She hated being fussed over. In his opinion, she could deal with it. She needed to get better...for both of their sakes. 

 The truck suddenly lurched, beginning its escape from Holland and the disastrous mission. 

 Roe shoved the Private next to her over, ignoring his protest, and slipped to her other side. Quietly he took her hand in his as his eyes scanned the others. He had been so focused on her; he did not even think about if any of the other men in the truck were injured. Luckily none were. 

 "I'm sorry I scared you. I had to help." She murmured, voice barely above the rumble of the trucks. 

 He sighed, squeezing her hand then pulled her closer into his side. "I know, mon amour, I know." He looked down, meeting those eyes he adored. "Doesn't mean I have to like it."

 She laid her head on his shoulder. "No, but you can't protect me from everything. This is war."

 "I can try. Tu es tout pour moi. J’ai besoin de toi à mes côtés. Toujours. Je promets après cette guerre de continuer à vous aimer et à vous chérir comme vous le méritez." The words poured forth, needing to be said, needing to be spoken aloud, even if just for his own sake. Though he meant them with all his heart. (You are everything to me. I need you by my side. Always. I promise after this war to continue to love and cherish you as you deserve.)

 "Gene, you know I don't speak French. It's not fair cause I wanna know what you're saying."

 "I'll teach you, y/n. I promise." He could not help but press a chaste kiss to the top of her head as they bounced along the road.

 Looking at the blue sky and clouds above, he prayed he would be able to fulfill both of his promises to her, that they would both make it through this war. Most of all, he prayed for her to be safe, even at the expense of his own life. 

[curryhealthcenter]

Harm Reduction: Speak Up, Speak Out 

HealthNut guest writer: Michael Layeux 

HealthNut photo: pexels.com 

Guest writer and advocate for drug policy and harm reduction, Michael Layeux, has joined as a guest to give a brief overview of what harm reduction is, what we as students can do to help reduce harm, and how to educate yourself on this topic. If you have any further questions or concerns about this topic, please reach out to Curry Health Center or someone you trust on campus to get help and information. Now without further ado here is what Michael had to say. 

What exactly is harm reduction? Why is it important? What does it have to do with me? Let’s start by exploring what it means for us in the context of substance use. 

Harm reduction is a philosophy of action that takes many diverse forms. That philosophy of action stems from the fundamental belief that all humanity is valuable and worthy of life. A major component of drug harm reduction is identifying what potential harms may exist for people who use substances; whether it be harmful policies surrounding substances and use, the stigma people who use substances suffer, the risks of an unregulated drug market, transmission of disease, or equitable access to safe supplies and lifesaving resources. Once these harms are identified, it is necessary to find ways to reduce or eliminate them. 

A key facet of harm reduction is reducing stigma for those who use substances. It is important to note that by recent estimates, only 11% of people who use some of the most stigmatized drugs develop dependence or a substance use disorder (Csete. J. et al, 2016). By cultivating an open and compassionate atmosphere around substance use, we can emotionally and physically be there for our friends and family, as well as ourselves. Practicing empathy and understanding is an important piece of harm reduction. If you use substances, or have loved ones who do, strive to create support networks and an honest, non-judgmental space about substance use. If we honestly learn to listen and care for one another, we can look out for our community and ensure people live safer and healthier lives. 

This critical philosophy can be practiced by every individual, as well as by groups. As individuals, the simplest form of harm reduction is practicing healthy habits: ensuring you have adequate sleep, proper hydration, exercise, etc. On the group scale, harm reduction organizations ensure equitable access of harm reduction materials to the most stigmatized and marginalized communities. They work tirelessly to provide lifesaving resources, education, and safe supplies to those that are most affected by the war on drugs, and the stigmatization of substance use. This can take forms such as: regularly testing people for HIV/Hep C., providing clean injection supplies, providing safer smoking and snorting supplies, providing narcan/naloxone (an opioid overdoes reversal agent), providing fentanyl testing strips, assisting with housing for HIV+ members of the community, and much more. 

“So, why is it important?” Well, for one we are in the midst of an overdose crisis that is directly caused by current drug laws and the unregulated drug market. Across the country overdoes deaths have risen dramatically in the past few years, even causing the CDC to release notice to all medical professionals and organizations to prioritize harm reduction efforts and tactics (Center for Disease Control, December 2020). Even here in Missoula fatal overdoses have increased 77% since 2019 (Missoula City/County Rx TaskForce). It is important to remember that each one of these deaths is a human life: a mother, a daughter, a son, a friend, or a partner. Each of these people are worthy and deserving of life, and it was taken from them by current attitudes and policies surrounding substance use. 

It is also incredibly important to note that non-fatal drug overdoses are increasing as well. You may wonder, “Why are overdoses increasing so dramatically?” The answer to that is a complex one. One of the largest factors is the fact that in the U.S. there is no safe and regulated supply to most substances, or free testing of these substances, as they are often criminalized unless prescribed. This causes unregulated drug markets to complete amongst each other to meet the demand in our country, which leads to cut/poisoned drug supplies. Another substantial factor is the prevalence of the drug Fentanyl and its many analogues in the unregulated drug market. 

Fentanyl is a synthetic opiate, like opium or morphine, but with a potency nearly 100x more than morphine, and 10x more than heroin. Some of the fentanyl analogues, such as carfentanil, are even 100x more potent that fentanyl. (National Center for Biotechnology Information, 2021). Fentanyl has been found in many drugs in the U.S. and here in Missoula. We know fentanyl to be in supplies of heroin, methamphetamine, cocaine, and even in pressed pills designed to replicate xanax or oxycodone, among other drugs. Due to the small amount of fentanyl required for a lethal dose (approximately 2 milligrams), many more people are overdosing. 

“How can we work to correct this issue?” “How do we know if the drugs we plan to take are adulterated?” The best thing we can do is to educate ourselves! Do personal research on the substances you would like to use, and take note of any interactions they might have with any prescriptions you may take or other substances you plan to use (Here are a few web resources: CAIRNmontana.org, Dancesafe.org, Erowid.org, combo.tripsit.me). Fentanyl testing strips are a cheap and effective way to check your drugs for fentanyl before ingesting them. Another incredibly valuable resource is narcan, an overdose reversal agent (in an easy to use nasal spray form). If you contact us at umontana@chapters.ssdp.org we will confidentially ship fentanyl testing strips to you at no cost, and can help you in accessing narcan. Also Open Aid Alliance (OAA) is a tremendously valuable resource in Missoula, and can offer fentanyl strips and narcan among many other harm reduction supplies and educational materials at no cost. 

We are hosting “Harm Reduction at the Oval” with OAA at UM on 3/31, 4/7, and 4/14 from 10am-3pm. Swing by for the free educational materials, free fentanyl testing strips and narcan as well as training, and other harm reduction materials!

Remember to practice love and compassion for yourself and your community. Be safe UM! 

[wenickjones]

Controlled Substances Market 2021 with Covid-19 Pandemic Analysis, Growth Rate, New Trend Analysis Forecast To 2027

Facto Market Insights as of late distributed statistical surveying report on the worldwide Controlled Substances Market to its assortment of statistical surveying reports. The exploration report covers point by point examination of market measuring and anticipating of the market covering the market drivers, challenges, opportunity investigation, and patterns, alongside different key bits of knowledge in the worldwide market. The examination report additionally incorporates the investigation of territorial producers and new market players, covering all the data reasonable for the customers to settle on essential business choices in the business.

Free Sample Report + All Related Graphs & Charts @  

https://www.factomarketinsights.com/sample/672

The report covers PESTLE examination and watchman's five powers investigation which exhibits the five powers including purchasers bartering power, providers haggling power, the danger of new participants, the danger of substitutes, and level of rivalry in the worldwide controlled substances market. In the investigation, the system of watchman's five powers examination clarifies the technique for breaking down the opposition of the business covering the business structure and the degree of rivalry in the market. Along with this, the exploration report additionally covers current realities and figures identified with the macroeconomic patterns that are expected to affect the development of the general market.

Following are the Main Features of Global Controlled Substances Market Report:

- Market Overview, Industry Development, Market Maturity, PESTLE Analysis, Value Chain Analysis

- Growth Drivers and Barriers, Market Trends & Market Opportunities

- Market Segments by Geographies and Countries

- Porter’s Five Forces Analysis & Trade Analysis

- Market Segment Trend and Forecast

- Market Forecast Analysis for 2021-2027

- Key Market Driving Factors

- Market Analysis and Recommendations

- Price Analysis

- Controlled Substances Market Company Analysis: Company Market Share & Market Positioning, Company Profiling, Recent Industry Developments etc.

Obtain Report Details @

https://www.factomarketinsights.com/report/672/controlled-substances-market

Market Segmentation:

The exploration offers an extensive investigation of worldwide controlled substances market concerning following sub-markets:

Controlled Substances Market, by Drug Class:

Opioids

Stimulants

Morphine

Fentanyl

Codeine

Meperidine

Methadone

Oxycodone

Others

Depressants

Methylphenidate

Dextroamphetamine

Amphetamine

Methamphetamine

Others

Marijuana

Barbiturates

Benzodiazepines

Medical Marijuana

Recreational Marijuana

Controlled Substances Market, by Distribution Channel:

Hospitals

Clinics

Retail Pharmacies

Rehabilitation Centers

Online

Controlled Substances Market, by Application:

Pain Management

Depression

Attention-Deficit/Hyperactivity Disorder (ADHD)

Seizure

Anxiety          

Sleep Disorders

Cough Suppression

Others

Regional Insights:

The report investigations the market by geologies for example North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Further, the regions are fragmented into the country and regional groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific)

- Latin America (Brazil, Mexico, and Rest of Latin America)

- Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa)

Competitive Landscape

The report includes profiles of leading companies in the global controlled substances market. Some of the key players profiled include:

Consort Medical

Cayman Chemical

Cambrex

Patheon

AMRI

Siegfried AG          

Johnson Matthey

SAFC/Cerilliant

Noramco, Inc

Mallinckrodt plc

Reasons to purchase the report:

- Identify possible investment areas based on a comprehensive trend analysis of the global controlled substances Market over the next few years.

- Gain in-depth knowledge of the underlying factors that drive demand for Controlled Substances and recognize the opportunities provided by them.

- Identify the major channels that drive the demand for TUNNEL LIGHTING, offering a strong image of potential prospects that can be tapped, resulting in growth in revenue.

- Strengthen the business knowledge in terms of industry dynamics, demand drivers, and the latest technological advances among others.

- Channelize funds by concentrating on the ongoing initiatives pursued by the numerous countries in the global controlled substances market.

Interested to Procure The Data? Inquire here at @

https://www.factomarketinsights.com/enquiry/672

About Us:

Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Our clients list includes various Fortune 500 companies and leading advisory firms.

Contact Us:

Facto Market Insights

90 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email:info@factomarketinsights.com

Website: www.factomarketinsights.com

[gb9525295]

How to Use Indonesia Market Research To Find New Niches And Business Opportunities ?

The Indonesia market is booming with a number of manufacturers. However, most of these manufacturers are yet to gain foothold in the enormous market. This is because of lack of awareness in the market and lessening the profitability in marketing the same products. As a result, the manufacturers are either forced out of the market or remain small in the industry.

With globalization, it's quite important for manufacturers to keep in tune with the current trends and conditions of the market. For doing this, they need to conduct Indonesia market research. Indonesian market research is conducted to study the customers preferences and buying habits of the buyers, so as to know if the product or service can cater to their needs and demands.

For conducting Indonesia market research, there are certain steps which can be followed by the manufacturers. The first step is to find a suitable site for gathering data. A number of Indonesia market research companies are available online and offer services for collecting and analyzing Indonesia market data. The Indonesia market research is then sent to the manufacturer, who can use this information to come up with improved products and services in the Indonesia market.

The second step involves setting up of an Indonesia market research unit. For doing this, it's important that the company you choose has well established analytical technologies and software for conducting Indonesia market research. A good Indonesia market research company should have well-established relationships with leading Indicators and market researchers.

A number of Indonesia market players are selling similar products in the local Indonesia market. These Indonesia market players might have many distributors and sales personnel in Indonesia and many warehouses across Indonesia. Some of these companies have distributors and sales people in different countries as well. They might have offices or branches in various countries worldwide.

To locate one of these Indonesia market players, search Indonesia market online directories for their contact details. For example, if you are looking for a Chinese distributor, search on the websites of Chinese distributor. You will also find Indonesia market players having registered trademarks in various countries across Asia. Such Indonesia market players will likely be part of the same family as the company that manufactures the product you want to sell. These companies have developed a reputation in the local Indonesia market as well as overseas.

The Indonesia market research company will conduct a thorough investigation of the company and the products it has to offer. It will carry out market research in terms of price, service, quality, quantity etc. It will also carry out a comprehensive background research on the company. Its aim will be to know the status of the company in the industry. It will carry out interviews with the directors, key personnel and customers of the Indonesia market research company.

All this work is undertaken with the sole aim of understanding Indonesia market fully so that it can help the company increase its business in Indonesia. When Indonesia market research reaches the point of identifying the weaknesses and the strengths of the company, then the Indonesia market research company will then work towards providing the solution. The Indonesia market research company will therefore help provide solutions for all your Indonesia market related problems. These Indonesia market research solutions are therefore very useful for all the companies involved in the manufacturing of clothing, shoe making, garment making, cosmetics, detergents, fruits and vegetables, etc.

The Indonesia market research company will first carry out a survey in the Indonesia market to find out the demand for any particular type of product in Indonesia. After this survey, the Indonesia market research company will make a study based on the consumer behavior and on the analysis of the sales patterns. Based on the study, they will provide you with a report on the areas which need improvement in the Indonesia market. These Indonesia market research report will then help the company improve on its services or products.

You can easily get Indonesia market reports from Indonesia market research companies. You can get these Indonesia market reports by searching Indonesia market research company on the internet. You can choose any Indonesia market research company depending on the quality of the service which you would like to avail. Make sure that you choose Indonesia market research company that does not charge you any fee for conducting the surveys. Only good Indonesia market research company can help you make better business.

Today, Indonesia market is flooded with a variety of goods. Therefore, competition is very high in Indonesia market. People from all over Indonesia are investing a lot in Indonesia market for making better business. You can get information about Indonesia market from Indonesia market research company. They will also provide you information about various Indonesia market products.

An intrathecal pump is a medical device used to deliver medications directly into the space between the spinal cord and the protective sheath surrounding the spinal cord. Medications such as baclofen, morphine, or ziconotide may be delivered in this manner to minimize the side effects often associated with the higher doses used in oral or intravenous delivery of these drugs.

Intrathecal pump is a surgically implanted system used to infuse potent medication directly into or around the spinal cord. These pumps are typically intended for use in chronic pain and spasticity management for delivering potent medicines in the intrathecal space which allows administration of drugs in very low doses.

 This report contains market size and forecasts of Intrathecal Pumps in Indonesia, including the following market information:

Indonesia Intrathecal Pumps Market Revenue, 2015-2020, 2021-2026, ($ millions)

Indonesia Intrathecal Pumps Market Consumption, 2015-2020, 2021-2026, (K Units)

Indonesia Intrathecal Pumps Production Capacity, 2015-2020, 2021-2026, (K Units)

Top Five Competitors in Indonesia Intrathecal Pumps Market 2019 (%)

The global Intrathecal Pumps market was valued at 256.7 million in 2019 and is projected to reach US$ 296.2 million by 2026, at a CAGR of 3.6% during the forecast period. While the Intrathecal Pumps market size in Indonesia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intrathecal Pumps manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Intrathecal Pumps production and consumption in Indonesia

Total Market by Segment:

Indonesia Intrathecal Pumps Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)

Indonesia Intrathecal Pumps Market Segment Percentages, By Type, 2019 (%)

Constant Rate Pump

Programmable Pump

 Indonesia Intrathecal Pumps Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)

Indonesia Intrathecal Pumps Market Segment Percentages, By Application, 2019 (%)

Chronic Pain

Spasticity Management

 Competitor Analysis

The report also provides analysis of leading market participants including:

Total Intrathecal Pumps Market Competitors Revenues in Indonesia, by Players 2015-2020 (Estimated), ($ millions)

Total Intrathecal Pumps Market Competitors Revenues Share in Indonesia, by Players 2019 (%)

Total Indonesia Intrathecal Pumps Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)

Total Indonesia Intrathecal Pumps Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

Medtronic

Codman & Shurtleff (J&J)

Flowonix

contax=ct us- https://www.reportmines.com/contact-us.php

[blog-site-for-market-research]

Insights into the Competitive Landscape of Pulmonary Edema Market

Market Overview –

The pulmonary edema market is witnessing advancements in understanding and managing this life-threatening condition. Pulmonary edema disease, characterized by fluid accumulation in the lungs, prompts a focus on innovative treatments targeting fluid reduction and improving oxygenation. With a growing emphasis on early intervention and personalized care, the market continues to evolve to meet patient needs.

The market for pulmonary edema is anticipated to grow at a rate of 7.10% CAGR from 2022 to 2030, reaching USD 11.2 billion.

The pulmonary edema market revolves around medical interventions and treatments targeting pulmonary edema, a condition characterized by the accumulation of fluid in the lungs. This accumulation impairs oxygen exchange, leading to symptoms like shortness of breath, coughing, and wheezing. The market comprises various treatment options, including medications, oxygen therapy, diuretics, and mechanical ventilation, aimed at managing symptoms, reducing fluid buildup, and improving respiratory function.

A significant driver of the pulmonary edema market is the prevalence of conditions that predispose individuals to fluid accumulation in the lungs, such as heart failure, pneumonia, kidney disease, and high altitude exposure. As the incidence of these underlying conditions rises globally, there is an increasing demand for effective interventions to prevent and manage pulmonary edema-related complications.

Advancements in medical technology have led to the development of innovative treatments and devices for pulmonary edema management. Non-invasive ventilation techniques, such as continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP), provide respiratory support and improve oxygenation in patients with acute respiratory distress due to pulmonary edema.

The COVID-19 pandemic has impacted the pulmonary edema market, with disruptions in healthcare services, changes in treatment protocols, and challenges in managing respiratory complications associated with severe COVID-19 infection. However, the pandemic has also accelerated innovation in respiratory care, leading to the development of novel therapies and approaches for managing pulmonary edema and other respiratory conditions.

Segmentation –

The global pulmonary edema market is segmented on the basis of type, diagnosis, treatment, and end user.On the basis of the type, the market is segmented into cardiogenic edema, cardiogenic edema, and others. On the basis of the diagnosis, the market is categorized into blood tests, imaging, and others. The blood tests segment is sub-segmented into b-type natriuretic peptide (BNP), blood count test, kidney function test, and others.

The imaging segment is sub-segmented into chest x-ray, electrocardiogram, echocardiogram, transesophageal echocardiography, pulse oximetry, and others. On the basis of the treatment, the market is segmented into preload reducers, morphine, suction catheter, and others. The preload reducers segment is sub-segmented into nitroglycerin, diuretics, and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Regional Analysis –

Regional analysis of the pulmonary edema market reveals disparities in disease prevalence, treatment options, and healthcare infrastructure across different regions. In developed regions like North America and Europe, where there is a higher incidence of heart failure and access to advanced cardiac care, the market for pulmonary edema management is well-established, with diuretics, oxygen therapy, and mechanical ventilation being standard treatments. Conversely, in developing regions with limited access to emergency medical services and critical care facilities, such as parts of Africa and Asia-Pacific, the market for pulmonary edema treatment is still emerging, with challenges related to late-stage presentation and resource constraints. Moreover, environmental factors such as air pollution and altitude influence the prevalence and severity of pulmonary edema in different regions. As awareness of heart failure risks and early symptoms increases globally, there is a growing opportunity for market expansion through education, capacity building, and investment in cardiovascular care infrastructure to improve outcomes for patients with pulmonary edema worldwide.

Key Players –

Pulmonary Edema Key players include Pfizer Inc. (U.S.), ARGON MEDICAL (U.S.), Edwards Lifesciences Corporation (U.S.), BD (U.S.), Alcaliber S.A. (Spain), Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), and Canon Medical Systems Corporation (Japan).

Related Reports –

Pain Patch

Electronic Trial Master File Systems

Neurology Devices

Medical Payment Fraud Detection

For more information visit at MarketResearchFuture

[omkarpatel]

The Opioids Agonist Drugs Market is Estimated To Witness High Growth Owing To Rising Pain Management Treatments

Opioids agonist drugs are a class of pain medications that help relieve moderate to severe pain. They work by binding to opioid receptors in the brain and central nervous system to alter pain perception and emotional response to pain. Some commonly used opioids agonist drugs include morphine, codeine, fentanyl, hydromorphone and oxycodone. They are highly effective for pain relief and widely prescribed for chronic pain associated with injuries, surgeries, cancer or other conditions. The opioids agonist drugs market is estimated to be valued at US$ 17,132.5 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends: Rising prevalence of chronic pain disorders like arthritis, low back pain and cancer pain is a key factor driving the demand for opioids agonist drugs. As per WHO data, around 1.5 billion people suffer from chronic pain globally. Moreover, increasing number of surgeries and accidents is also contributing to the growth of chronic pain patient population. Opioid drugs are recommended as first line treatment for moderate to severe pain. Growing geriatric population prone to musculoskeletal disorders is another growth promoter for this market. However, concerns around opioid addiction and abuse may hamper the market growth over the forecast period. Pharmaceutical companies are developing novel analgesic drugs as an alternative to traditional opioids to address this issue. Porter’s Analysis

Threat of new entrants: The opioids agonist drugs market faces moderate threat of new entrants due to high R&D costs and patent protections for existing drugs. However, availability of generic opioids offers opportunities for small players. Bargaining power of buyers: Buyers have moderate bargaining power due to presence of many manufacturers. However, usage of opioids for pain management gives buyers less negotiating power. Bargaining power of suppliers: Suppliers have low bargaining power given fragmented nature of raw material suppliers and input availability from different sources globally. Threat of new substitutes: Threat from new substitutes is low as opioids drugs are irreplaceable for pain management. However, non-opioid drugs are gaining popularity. Competitive rivalry: High due to many global and local players competing on basis of patents, drug efficacy and diversified product portfolio. SWOT Analysis Strength: Wide acceptability of opioids for pain management. Established distribution channel and brand presence globally. Weakness: Stringent regulations regarding opioids prescription and abuse potential. Side effects associated with prolonged usage. Opportunity: Untapped growth potential in emerging markets. New pipeline drugs offering safer profiles and formulations. Threats: Increasing non-opioid substitutes. Generic erosion once patents expires. Regulatory hurdles and litigation over addictive properties.

Key Takeaways The global opioids agonist drugs market is expected to witness moderate growth, exhibiting CAGR of 4.2% over the forecast period, due to rising prevalence of chronic pain indications like cancer pain and arthritis and growing geriatric population prone to orthopedic conditions. Regionally, North America dominated the global market in 2023 and is expected to maintain its lead over the forecast period as well due to availability of advanced healthcare facilities and prescription drug abuse epidemic in the US. Asia Pacific market is poised to witness fastest growth due to improving access to healthcare in major economies like India and China and growing medical tourism industry. Key players operating in the opioids agonist drugs market are Advaxis, Inc., Cellectar Biosciences, Inc., OPKO Health, Inc., Pfizer Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Debiopharm Group, Merck & Co, Bayer AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical, F. Hoffmann-La Roche Ltd and Teva Pharmaceutical. Major players are focusing on developing novel long-acting formulations,combinations and abuse-deterrent opioid drugs to consolidate their market share.

[mercuryismygenius]

Book Review: ‘Dreamland’

Dreamland: The True Tale of America’s Opiate Epidemic by Sam Quinones

In Dreamland, Sam Quinones tackles the current opioid crisis in the United States with impressive thoroughness. His goal in researching the epidemic was The Big Picture---unfortunately, such comprehensiveness may not be possible. Nonetheless, he does an admirable job, making Dreamland one of the few should-reads for contemporary America.

There is a lot in this book. Broadly speaking, the material can be divided into two basic categories: the legal, and the illegal (specifically represented by Oxycontin, and Black Tar heroin, respectively). Broadly speaking.

On the legal side, Quinones interviews doctors, researchers, nurses, clinicians, patients-cum-addicts, Oxycontin dealers, and families of the lost; he has chapters on the poppy plant, opium, and morphine; he discusses Arthur Sackler and the rise of pharmaceutical marketing, which included the wooing of doctors; and he traces the history of pain treatment---the medical treatment of pain being one of the largest enablers of the opium epidemic.

It’s hard to call what occurred in the medical establishment an overt conspiracy since, outside Big Pharma, most intention was good. Most. 

It began because opium derivatives are pain killers---and the pain-killing properties of opium are ancient news. Also well-known was the fact that opioids are addictive, and use was restricted and monitored. Cancer changed that, with doctors advocating the use of morphine, etc. for end-stage cancer patients who were dying in horrible pain. At that point, it was a quality-of-life issue, and the campaign was successful.

Unfortunately, around the same time that pharmaceutical companies were honing their marketing skills, and developing opium-derivatives, medicine decided to extend the quality-of-life logic to all forms of pain. Injured? Opioid. Chronic back pain because you don’t lift with your legs? Opioid. Whatever the pharmaceutical company had, that was the solution.

And as for that habit-forming problem of opium-derivatives? Turns out, according to an infamous “study” referred to as Porter and Jick, opioids aren’t really that addictive after all. That Porter and Jick was really just a letter to the editor noting one pattern in a limited pool of data either didn’t matter, or, more probably, was never known by the people who cited it (a couple of whom Quinones interviews). Yes, bad science became a major contributor to our opioid crisis. No one checked the “study” that was repeated ad nauseam, and few paid attention to the data at hand concerning the high rates of addiction in patients who were prescribed Oxycontin.

Insurance companies didn’t help matters. They’d pay for prescription medication, but not for physical therapy, psychotherapy, nutritionists, or holistic/ multidisciplinary approaches to pain treatment. So doctors who wanted to use those non-pill approaches were put out of business.

But that’s just the legal opioids. On the illegal side, Quinones focuses on Black Tar Heroin, a viscous, dark-colored substance that’s as pure as heroin can get. He interviews cops, dealers, DEA agents, addicts, lawyers, and community organizers. And because he follows the Black Tar, he discusses Xaliso, a city in the state of Narayit in Mexico, where the heroin was grown.

Black Tar heroin dealers changed the game. Just about everything about them confounded police. The dealers didn’t carry guns, didn’t fight turf wars, and feared local gangs. They didn’t use, and they didn’t adulterate their product by cutting it---they didn’t need to as there was no multilevel distribution line. They delivered to their customers, carrying a minimum of heroin, so if caught, D.A.s rarely felt they were worth the time, and they were just deported.

Deportation was not a deterrent. The Xalisco Boys, as Quinones calls them, dealt heroin in order to make money and be the Big Man struttin’ around town back home. In the United States, their lives were spartan---the point was to go back home to their sugarcane-farming town, having struck it rich. Unfortunately, the dealers spent too lavishly, didn’t invest or save, so money ran out, and they had to return to the U.S.

The system the Xalisco Boys had was capitalism at its finest. No corporate headquarters, no cartel bigwigs, just small entrepreneurs competing in an open market. They had excellent customer service. Not only did they deliver like pizza, they offered samples, and deals. Addicts would get extra heroin for introducing a new customer. The Xalisco Boys would pay (in heroin) for an addict to hand out samples at the local methadone clinic. They’d exchange drugs for your name on an apartment or car lease. And when word got back to Narayit of ripe territory, a gold-rush mentality set in, and more cells would show up in town to compete for the same customers. Prices dropped.

Besides being non-violent in general, in Xalisco, the culture included webs of long-standing family feuds that few wanted to challenge. Because if anything untoward happened in the U.S., it *would* get back to Mexico.

Thus the more adventurous dealers would strike out for new territory. If an addict happened to know of another possibly-lucrative town, they’d introduce the Boys. 

One dealer Quinones interviews, called The Man, was actually born in the U.S., and entered the Xalisco system from the outside. Of Mexican descent, he spoke English and Spanish, and recognized the relevance of Oxycontin to heroin sales (most of the Xalisco Boys didn’t bother learning more than functional English, so didn’t see the bonanza). He was arrested before he could really pave the way, but others did so after him.

Part One of the book ends with the arrest of numerous dealers in multiple states in one of the largest, most coordinated operations in drug-enforcement history. But the insidiousness of the Xalisco system is that it’s self-renewing. Arrest one guy, someone else will take his place. As long as there’s demand.

As I stated above, there is a lot in this book. Quinones manages this plethora of information by “braiding” or “juggling” it: he tells the story of the family of a young man who od’d; introduces a dealer called Enrique; moves to Dr. Herschel Jick wondering about rates of narcotic addiction in patients at his hospital; reveals how Dr. David Proctor came to Portsmouth, OH (he wasn’t able to interview Proctor in person); Enrique again; a cop in Denver; the morphine molecule; Proctor; Enrique; a cop in Idaho; Xalisco culture---this is not the actual order he goes in, but it is the gist of his technique. He touches base with each thread, showing how they interweave. It’s an interesting approach that I think works well for the material, but it did get difficult sometimes to remember who was who. I’d use the index in those cases.

Two limits before I end this already long review. First, the heroin angle is limited to the Black Tar out of Xalisco. Other heroin dealers, gangs, cartels, etc. are mentioned only when relevant to Black Tar and the Xalisco system. So, for example, the Xalisco Boys avoided New York City like the plague, so not much about the presence of heroin there in Dreamland.

Second, racism is prevalent throughout, but not explicitly explored (this is a limit, not a detraction). The Xalisco Boys would not deal to blacks if they could help it---mostly out of fear derived from prejudice. But the far more subtle forms of racism, especially in the predominantly white middle-American towns exist like smog---it’s there, it’s not good, but those immersed in it stopped noticing. Quinones points it out a couple of times, but the degree to which it’s relevant is up to the reader (since his topic isn't the various connections between racism and drugs, he may have decided to just let instances of racism stink up the background and not turn Dreamland into a doorstop).

Highly recommend this book.